Vertex Pharmaceuticals, Transocean, And 'One Of The Best Companies' In Staples: CNBC's 'Final Trades'

On CNBC’s “Halftime Report Final Trades,” Jim Lebenthal of Cerity Partners chose Transocean Ltd RIG, after the company reported its first-quarter results. EBITDA was “a lot better than expected,” he said.

“Rig day rates are going up. This is going to be a home run,” Lebenthal added.

Benzinga's analyst ratings data shows a consensus Neutral rating on Transocean.

Joseph Terranova of Virtus Investment Partners said Vertex Pharmaceuticals Incorporated VRTX had a “strong earnings report.” The stock has the potential to trade above $400, Terranova added.

Check out other stocks making moves in the premarket.

Jenny Harrington of Gilman Hill Asset Management said Procter & Gamble Co. PG was “one of the best companies that reported in staples.” The company’s organic growth of 7% helped “beat earnings, revenues, and margins,” while pushing the guidance higher, she added.

Also Read: Elon Musk Says People In The Future 'Probably Won't Even Need To Pay' For Drugs To Get High

Loading...
Loading...
PG Logo
PGProcter & Gamble Co
$158.750.01%

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings
Edge Rankings
Momentum
33.34
Growth
90.72
Quality
43.08
Value
22.99
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs

Comments
Loading...